norethindrone acetate has been researched along with Cardiovascular Stroke in 2 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Excerpt | Relevance | Reference |
---|---|---|
" The Women's Health Initiative trial demonstrated that taking the combination of conjugated estrogen and medroxyprogesterone resulted in a higher risk of myocardial infarction and stroke in the study population." | 4.86 | Progesterone, progestins, and the heart. ( Bernstein, P; Pohost, G, 2010) |
"The hazard ratio for deep vein thrombosis (2 in treated group v 1 in control group) was 2." | 2.77 | Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. ( Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernstein, P | 1 |
Pohost, G | 1 |
Schierbeck, LL | 1 |
Rejnmark, L | 1 |
Tofteng, CL | 1 |
Stilgren, L | 1 |
Eiken, P | 1 |
Mosekilde, L | 1 |
Køber, L | 1 |
Jensen, JE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Danish Osteoporosis Prevention Study[NCT00252408] | Phase 4 | 2,000 participants | Interventional | 1990-10-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for norethindrone acetate and Cardiovascular Stroke
Article | Year |
---|---|
Progesterone, progestins, and the heart.
Topics: Coronary Vessels; Estrogen Replacement Therapy; Humans; Medroxyprogesterone; Myocardial Infarction; | 2010 |
1 trial available for norethindrone acetate and Cardiovascular Stroke
Article | Year |
---|---|
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
Topics: Breast Neoplasms; Contraceptives, Oral, Synthetic; Denmark; Estradiol; Estrogens; Female; Follicle S | 2012 |